Arcadia Biosciences Priced, Nasdaq: RKDA

Developing a portfolio of crop productivity traits for genetically modified seeds.

Industry: Materials

Latest Trade: $0.72 0.00 (0.0%)

First Day Return: -8.8%

Return from IPO: -91.0%

Industry: Materials

We are a leading agricultural biotechnology trait company with an extensive and diversified portfolio of late-stage yield and product quality traits addressing multiple crops that supply the global food and feed markets. We have achieved this leadership position based on our development collaborations with global agricultural leaders, recognition by third parties, and our track record of success in trait development since our founding in 2002. Our traits are focused on high-value enhancements that increase crop yields by enabling plants to more efficiently manage environmental and nutrient stresses, and that enhance the quality and value of agricultural products. Our traits increase value not only for farmers, but also for users of agricultural products. Our target market is the $39.4 billion global seed market. Our goal is to increase the value of this market significantly by increasing yields, and to capture a portion of the increased value. There currently are more than 50 products in development incorporating our traits and there are 13 that have demonstrated efficacy in field trials, one that is in the process of completing the regulatory process, and one that is currently on the market.
more less
IPO News for Arcadia Biosciences
more
IPO Data
IPO File Date 02/17/2015
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 8.2
Deal Size ($mm) $66
IPO Data
IPO Date 05/14/2015
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 8.2
Deal Size ($mm) $66
Underwriters
more
Company Data
Headquarters Davis, CA
Founded 2002
Employees 76
Website www.arcadiabio.com